查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
激素避孕藥市場規模、份額和趨勢分析報告：按方法（宮內節育器、藥丸、植入物）、按激素（組合激素避孕藥、僅黃體酮）、按地區、按細分市場、預測 2022-2030 年
市場調查報告書
商品編碼
1122304

激素避孕藥市場規模、份額和趨勢分析報告：按方法（宮內節育器、藥丸、植入物）、按激素（組合激素避孕藥、僅黃體酮）、按地區、按細分市場、預測 2022-2030 年

Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (IUDs, Pills, Implants), By Hormone (Combination Hormonal Contraceptives, Progestin-only), By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

激素避孕藥市場增長和趨勢

根據 Grandview Research 的一份新報告，到 2030 年，全球激素避孕藥市場預計將達到 242 億美元。預計在預測期內的複合年增長率為 4.29%。在新興地區引進創新產品和提高對生殖和性健康的認識可能是增長的驅動力。在新興經濟體，越來越多的政府舉措和計劃正在增加使用避孕藥具的女性人數。預計這些因素將加速市場的增長。例如，根據聯合國 2020 年世界生育和計劃生育報告，2019 年，49% 的育齡婦女使用某種形式的避孕措施來避免懷孕，其中 91% 的人使用了植入物、補片或宮內節育器。使用最新的避孕方法，包括

根據聯合國人口基金會的《2022 年世界人口狀況》，全世界每年 1.21 億次懷孕中約有 50% 是意外懷孕。為了避免不安全的墮胎，各國正在提高對避孕藥具的認識，這有望推動該行業的發展。由於新設備的推出、長效可逆避孕方法的可用性以及超過 99.0% 的功效，預計 IUD 細分市場在預測期內增長最快。

由於供應鏈中斷和計劃生育人數下降，COVID-19 流行病對該行業產生了重大影響。默克公司等避孕藥具製造商報告稱，隨著醫療保健提供者優先治療 COVID-19 患者，對其 Nexplanon 避孕植入物的需求下降。此外，由於各種仿製藥的引入，行業分散。例如，2019 年 12 月，Plasco 與默克公司合作，推出了 NuvaRing 的仿製藥，一種含有乙炔雌二醇的陰道環。

激素避孕藥市場報告亮點

對避孕藥具的高需求是由於人們對藥丸和設備的認識提高、計劃生育的重要性以及政府支持政策改善了這些產品的獲取。

按激素計算，由於副作用較少，出現痤瘡和相關症狀的可能性較小，2021 年聯合激素避孕藥佔最大份額。

該藥丸在 2021 年擁有最高的市場份額，因為它易於使用，如果服用得當，有效率超過 99.0%。

此外，易用性、副作用少和大量玩家為這一細分市場的增長做出了貢獻。

北美將在 2021 年佔據最大份額，由於主要市場參與者的存在、高人均收入和政府支持措施，預計在預測期內將保持其主導地位。

由於未滿足的高需求、預計未來 15 年覆蓋面的增加以及育齡婦女的增加，亞太地區預計將在 2022 年至 2030 年期間實現最快的複合年增長率

目錄

第一章研究範圍與目的

  • 市場細分
  • 區域範圍
  • 研究目標

第二章研究方法論

  • 調查方法
    • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
    • 體積分析
  • 二級信息列表
  • 縮略語表

第三章執行摘要

  • 市場展望
  • 分部展望
    • 激素
    • 方法
  • 區域展望
  • 競爭考慮

第 4 章市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 相關/子公司市場展望
  • 激素避孕藥市場動態
    • 市場驅動力分析
      • 政府和非政府組織倡議推廣避孕方法的興起
      • 高未滿足的需求
    • 市場約束分析
      • 人口迅速老齡化和不孕症患病率上升
      • 與使用避孕藥具和避孕裝置相關的不良反應
  • 激素避孕藥市場：商業環境分析工具
    • 波特五力分析
    • 杵分析
      • 政治與法律
      • 經濟與社會
      • 技術的
  • 繪製滲透率和增長前景
  • 定性分析：COVID-19 對激素避孕藥市場的影響

5 激素避孕藥市場：激素分析

  • 2021 年和 2030 年激素避孕激素市場份額分析
  • 激素避孕激素市場：細分儀表板
  • 激素細分市場規模和預測，趨勢分析，2017-2030
    • 複方激素避孕藥
    • 僅孕激素

6 激素避孕藥市場：方法分析

  • 2021 年和 2030 年激素避孕藥市場份額分析
  • 激素避孕藥市場：細分儀表板
  • 方法細分市場規模和預測，趨勢分析，2017-2030
    • 藥丸
    • 宮內節育器（IUD）
    • 可注射的
    • 陰道環
    • 注入
    • 修補

7. 激素避孕藥市場：區域分析

  • 2020 年和 2030 年激素避孕藥區域市場份額分析
  • 區域市場快照
  • 2017-2030 年市場規模、預測和趨勢分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 意大利
      • 西班牙
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 澳大利亞
      • 韓國
    • 拉丁美洲
      • 墨西哥
      • 巴西
      • 阿根廷
    • 中東和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

第 8 章 競爭分析

  • 主要市場參與者的最新發展和影響分析
  • 競爭對手分類（主要創新者、市場領導者、初創企業）
  • 公司市場分析
  • 公司簡介
    • ABBVIE INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • BAYER AG
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Organon group of companies.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • PFIZER
      • 公司簡介
      • 財務績效
      • 產品基準
    • AFAXYS, INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • TEVA PHARMACEUTICAL INDUSTRIES LTD
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • AGILE THERAPEUTICS
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • JANSSEN PHARMACEUTICALS, INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Lupin Pharmaceuticals, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Pregna International Limited.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: GVR-2-68038-348-5

Hormonal Contraceptive Market Growth & Trends:

The global hormonal contraceptive market size is expected to reach USD 24.2 billion by 2030, based on a new report by Grand View Research, Inc. It is projected to register a CAGR of 4.29% during the forecast period. The introduction of innovative products and growing awareness about reproductive & sexual health in emerging regions are likely to drive the growth. An increasing number of women in developing economies are using contraceptives due to the rise in government initiatives and programs. This factor is anticipated to accelerate market growth. For instance, according to the UN World Fertility and Family Planning 2020, in 2019, 49% of the women of reproductive age received some form of contraception to avoid pregnancy with 91% of women among them using modern contraceptive methods including implants, patches, IUDs, and others.

According to the State of World Population 2022, by UNFPO, globally, approximately 50% of all 121 million pregnancies each year are unwanted. As per the Seeing, the Unseen: The case for action in the neglected crisis of unintended pregnancy, more than 60% of unwanted pregnancies result in abortion and the projected 45% among them are unsafe. Hence, to avoid unsafe abortions, countries are spreading awareness about contraceptives, which is expected to propel industry growth. The IUD segment is expected to witness the fastest growth during the forecast period due to the entry of new devices, the availability of long-acting reversible birth control methods, and more than 99.0% effectiveness.

The COVID-19 pandemic has significantly impacted the industry owing to supply chain disruptions and a decline in family planning numbers. Contraceptive manufacturers, such as Merck & Co., have reported reduced demand for the contraceptive implant, Nexplanon, due to the prioritization of COVID-19 patients by healthcare providers. The industry is fragmented owing to the introduction of various generic drugs. For instance, in December 2019, Prasco, in collaboration with Merck & Co., Inc., launched the generic version of the NuvaRing, a vaginal ring containing ethinylestradiol.

Hormonal Contraceptive Market Report Highlights:

  • High demand for contraceptive methods can be attributed to the rising awareness about pills & devices, the significance of family planning, and the presence of supportive government policies improving access to these products
  • By hormone, the combination hormonal contraceptive segment held the largest share in 2021 owing to the fewer side effects and lower chances of developing acne and related symptoms
  • Based on method, pills accounted for the largest share in 2021 as these products are convenient to use and exhibit more than 99.0% effectivity when accurately consumed
  • Furthermore, the ease of availability, fewer adverse effects, and the presence of a large number of players contribute to the segment growth
  • North America held the largest share in 2021 and is anticipated to maintain its dominance during the forecast period due to the presence of major market players, high per capita income, and supportive government initiatives
  • The Asia Pacific is estimated to witness the fastest CAGR from 2022 to 2030 due to high unmet needs, an expected increase in coverage in the next 15 years, and an increasing number of women in their reproductive age

Table of Contents

Chapter 1 Report Scope and Objectives

  • 1.1 Market Segmentation
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecast Timeline
  • 1.4 Research Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3

Chapter 2 Methodology

  • 2.1 Research Methodology
    • 2.1.1 Information procurement
    • 2.1.2 Purchased Database
    • 2.1.3 GVR's Internal Database
    • 2.1.4 Secondary Sources
    • 2.1.5 Primary Research
  • 2.2 Information or Data Analysis
    • 2.2.1 Data Analysis Models
  • 2.3 Market Formulation & Validation
  • 2.4 Model Details
    • 2.4.1 Commodity Flow Analysis
    • 2.4.2 Volume price analysis
  • 2.5 List of Secondary Sources
  • 2.6 List of Abbreviations

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Segment Outlook
    • 3.2.1 Hormone
    • 3.2.2 Method
  • 3.3 Regional Outlook
  • 3.4 Competitive Insights

Chapter 4 Market Variables, Trends & Scope

  • 4.1 Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
    • 4.1.2 Related/Ancillary Market Outlook
  • 4.2 Hormonal Contraceptive Market Dynamics
    • 4.2.1 Market Driver Analysis
      • 4.2.1.1 Rise in government and NGO initiatives to promote contraceptive methods
      • 4.2.1.2 High unmet needs
    • 4.2.2 Market Restraint Analysis
      • 4.2.2.1 Rapidly aging population and rising prevalence of infertility
      • 4.2.2.2 Adverse effects associated with the use of contraceptive drugs and devices
  • 4.3 Hormonal Contraceptive Market: Business Environment Analysis Tools
    • 4.3.1 Porter's five forces analysis
    • 4.3.2 PESTLE Analysis
      • 4.3.2.1 Political & legal
      • 4.3.2.2 Economic & Social
      • 4.3.2.3 Technological
  • 4.4 Penetration & Growth Prospect Mapping
  • 4.5 Qualitative Analysis: Impact of COVID-19 on the Hormonal Contraceptive Market

Chapter 5 Hormonal Contraceptive Market: Hormone Analysis

  • 5.1 Hormonal Contraceptive Hormone Market Share Analysis, 2021 & 2030
  • 5.2 Hormonal Contraceptive Hormone Market: Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the Hormone Segment
    • 5.3.1 Combination Hormonal Contraceptives
      • 5.3.1.1 Combination hormonal contraceptives market, 2017 - 2030 (USD Million)
    • 5.3.2 Progestin-only
      • 5.3.2.1 Progestin-only market, 2017 - 2030 (USD Million)

Chapter 6 Hormonal Contraceptive Market: Method Analysis

  • 6.1 Hormonal Contraceptive Method Market Share Analysis, 2021 & 2030
  • 6.2 Hormonal Contraceptive Method Market: Segment Dashboard
  • 6.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the Method Segment
    • 6.3.1 Pills
      • 6.3.1.1 Pills market, 2017 - 2030 (USD Million)
    • 6.3.2 Intrauterine Devices (IUD)
      • 6.3.2.1 Intrauterine Devices (IUD) market, 2017 - 2030 (USD Million)
    • 6.3.3 Injectable
      • 6.3.3.1 Injectable market, 2017 - 2030 (USD Million)
    • 6.3.4 Vaginal Ring
      • 6.3.4.1 Vaginal Ring market, 2017 - 2030 (USD Million)
    • 6.3.5 Implant
      • 6.3.5.1 Implant market, 2017 - 2030 (USD Million)
    • 6.3.6 Patch
      • 6.3.6.1 Patch market, 2017 - 2030 (USD Million)

Chapter 7 Hormonal Contraceptive Market: Regional Analysis

  • 7.1 Hormonal Contraceptive Regional Market Share Analysis, 2020 & 2030
  • 7.2 Regional Market Snapshot
  • 7.3 Market Size, & Forecasts and Trend Analysis, 2017 to 2030
    • 7.3.1 North America
      • 7.3.1.1 North America Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.1.2 U.S.
      • 7.3.1.2.1 U.S. Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.1.3 Canada
      • 7.3.1.3.1 Canada Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
    • 7.3.2 Europe
      • 7.3.2.1 Europe Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.2.2 U.K.
      • 7.3.2.2.1 U.K. Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.2.3 Germany
      • 7.3.2.3.1 Germany Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.2.4 France
      • 7.3.2.4.1 France Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.2.5 Italy
      • 7.3.2.5.1 Italy Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.2.6 Spain
      • 7.3.2.5.1 Spain Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
    • 7.3.3 Asia Pacific
      • 7.3.3.1 Asia Pacific Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.3.2 Japan
      • 7.3.3.2.1 Japan Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.3.3 China
      • 7.3.3.3.1 China Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.3.4 India
      • 7.3.3.4.1 India Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.3.5 Australia
      • 7.3.3.5.1 Australia Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.3.6 South Korea
      • 7.3.3.6.1 South Korea Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
    • 7.3.4 Latin America
      • 7.3.4.1 Latin America Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.4.2 Mexico
      • 7.3.4.2.1 Mexico Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.4.3 Brazil
      • 7.3.4.3.1 Brazil Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.4.4 Argentina
      • 7.3.4.4.1 Argentina Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
    • 7.3.5 Middle East & Africa
      • 7.3.5.1 Middle East & Africa Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.5.2 South Africa
      • 7.3.5.2.1 South Africa Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.5.2 Saudi Arabia
      • 7.3.5.2.1 Saudi Arabia Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.5.3 UAE
      • 7.3.5.3.1 UAE Hormonal Contraceptive Market, 2017 - 2030 (USD Million)

Chapter 8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 8.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
  • 8.3 Company Market Position Analysis
  • 8.4 Company Profiles
    • 8.4.1 ABBVIE INC.
      • 8.4.1.1 Company overview
      • 8.4.1.2 Financial performance
      • 8.4.1.3 Product benchmarking
      • 8.4.1.4 Strategic initiatives
    • 8.4.2 BAYER AG
      • 8.4.2.1 Company overview
      • 8.4.2.2 Financial performance
      • 8.4.2.3 Product benchmarking
      • 8.4.2.4 Strategic initiatives
    • 8.4.3 Organon group of companies.
      • 8.4.3.1 Company overview
      • 8.4.3.2 Financial performance
      • 8.4.3.3 Product benchmarking
      • 8.4.3.4 Strategic initiatives
    • 8.4.4 PFIZER
      • 8.4.4.1 Company overview
      • 8.4.4.2 Financial performance
      • 8.4.4.3 Product benchmarking
    • 8.4.5 AFAXYS, INC.
      • 8.4.5.1 Company overview
      • 8.4.5.2 Financial performance
      • 8.4.5.3 Product benchmarking
      • 8.4.5.4 Strategic initiatives
    • 8.4.6 TEVA PHARMACEUTICAL INDUSTRIES LTD
      • 8.4.6.1 Company overview
      • 8.4.6.2 Financial performance
      • 8.4.6.3 Product benchmarking
      • 8.4.6.4 Strategic initiatives
    • 8.4.7 AGILE THERAPEUTICS
      • 8.4.7.1 Company overview
      • 8.4.7.2 Financial performance
      • 8.4.7.3 Product benchmarking
      • 8.4.7.4 Strategic initiatives
    • 8.4.8 JANSSEN PHARMACEUTICALS, INC.
      • 8.4.8.1 Company overview
      • 8.4.8.2 Financial performance
      • 8.4.8.3 Product benchmarking
      • 8.4.8.4 Strategic initiatives
    • 8.4.9 Lupin Pharmaceuticals, Inc.
      • 8.4.9.1 Company overview
      • 8.4.9.2 Financial performance
      • 8.4.9.3 Product benchmarking
      • 8.4.9.4 Strategic initiatives
    • 8.4.10 Pregna International Limited.
      • 8.4.10.1 Company overview
      • 8.4.10.2 Financial performance
      • 8.4.10.3 Product benchmarking
      • 8.4.10.4 Strategic initiatives

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviations
  • TABLE 3 Global hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 4 Global hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 5 North America hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
  • TABLE 6 North America hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 7 North America hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 8 U.S. hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 9 U.S. hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 10 Canada hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 11 Canada hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 12 Europe hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
  • TABLE 13 Europe hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 14 Europe hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 15 Germany hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 16 Germany hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 17 U.K. hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 18 U.K. hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 19 France hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 20 France hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 21 Italy hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 22 Italy hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 23 Spain hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 24 Spain hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 25 Asia Pacific hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
  • TABLE 26 Asia Pacific hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 27 Asia Pacific hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 28 Japan hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 29 Japan hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 30 China hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 31 China hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 32 India hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 33 India hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 34 Australia hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 35 Australia hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 36 South Korea hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 37 South Korea hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 38 Latin America hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
  • TABLE 39 Latin America hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 40 Latin America hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 41 Brazil hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 42 Brazil hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 43 Mexico hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 44 Mexico hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 45 Argentina hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 46 Argentina hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 47 Middle East & Africa (MEA) hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
  • TABLE 48 Middle East & Africa (MEA) hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 49 Middle East & Africa (MEA) hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 50 South Africa hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 51 South Africa hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 52 Saudi Arabia hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 53 Saudi Arabia hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 54 UAE hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 55 UAE hormonal contraceptive market, by method, 2017 - 2030 (USD Million)

List of Figures

  • FIG. 1 Hormonal contraceptives market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 Hormonal contraceptive market outlook, 2021
  • FIG. 10 Hormonal contraceptive market trends & outlook
  • FIG. 11 Market driver relevance analysis (Current & future impact)
  • FIG. 12 Market restraint relevance analysis (Current & future impact)
  • FIG. 13 Penetration & growth prospect mapping
  • FIG. 14 Hormonal contraceptives market: Hormone movement analysis (USD Million)
  • FIG. 15 Hormonal contraceptives market hormone outlook: Key takeaways (USD Million)
  • FIG. 16 Combination hormonal contraceptives market, 2017 - 2030 (USD Million)
  • FIG. 17 Progestin-only market, 2017 - 2030 (USD Million)
  • FIG. 19 Pill market, 2017 - 2030 (USD Million)
  • FIG. 20 Hormonal contraceptives market: Method movement analysis (USD Million)
  • FIG. 21 Hormonal contraceptives market method outlook: Key takeaways (USD Million)
  • FIG. 22 Intrauterine device market, 2017 - 2030 (USD Million)
  • FIG. 23 Injectable market, 2017 - 2030 (USD Million)
  • FIG. 24 Vaginal ring market, 2017 - 2030 (USD Million)
  • FIG. 25 Implant market, 2017 - 2030 (USD Million)
  • FIG. 26 Patch market, 2017 - 2030 (USD Million)
  • FIG. 27 Regional outlook, 2021 & 2030
  • FIG. 28 Regional marketplace: Key takeaways
  • FIG. 29 North America hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 30 U.S. hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 31 Canada hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 32 Europe hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 33 U.K. hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 34 Germany hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 35 France hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 36 Italy hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 37 Spain hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 38 Asia Pacific hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 39 Japan hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 40 China hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 41 Australia hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 42 South Korea hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 43 Latin America hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 44 Brazil hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 45 Mexico hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 46 Argentina hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 47 MEA hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 48 South Africa hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 49 Saudi Arabia hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 50 UAE hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 51 Recent developments and impact analysis
  • FIG. 52 Company categorization
  • FIG. 53 Company market position analysis